Glutathione is a tripeptide with cysteine being a component
These users report appreciating treatment benefits while active but watching improvements gradually fade over months post-discontinuation, with timeline showing first 2 months maintaining most benefits creating initial optimism, months 2-4 showing noticeable decline returning toward baseline, months 4-8 continuing regression approaching pre-treatment status, and stabilization occurring 60-80% back toward original baseline with only modest long-term improvement retention
Especially helpful after having one too many
NAC benefits include: Direct glutathione precursor support Improved antioxidant status Better detoxification capacity Better respiratory health Most studies use doses between 600-1800mg daily
Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin
Das RP, Jain AK, Ramesh V